| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Issuance( Retirement)of Debt Net | -405.93 | 1,462.81 | 809.09 | 33.50 |
| Net Changein Cash | 105.49 | 38.22 | 5.15 | 13.96 |
| Cash Taxes Paid | 97.88 | 100.75 | 77.21 | 83.29 |
| Net Income/ Starting Line | 488.87 | 431.24 | 404.64 | 442.20 |
| Total Cash Dividends Paid | -100.05 | 0.00 | -99.91 | -81.62 |
| Changesin Working Capital | 29.86 | -172.53 | -245.25 | -113.19 |
| Cashfrom Operating Activities | 1,066.78 | 512.97 | 299.23 | 378.26 |
| Cash Interest Paid | 145.06 | 77.30 | 23.43 | 3.85 |
| Cashfrom Financing Activities | -881.32 | 1,379.78 | 688.03 | -44.70 |
| Issuance( Retirement)of Stock Net | 7.22 | 4.54 | 2.28 | 6.75 |
| Depreciation/ Depletion | 315.46 | 182.61 | 117.09 | 64.71 |
| Other Investing Cash Flow Items Total | 75.03 | -1,725.36 | -140.68 | -198.58 |
| Capital Expenditures | -155.00 | -129.16 | -841.42 | -121.03 |
| period Type | - | - | - | - |
| Non- Cash Items | 232.59 | 71.65 | 22.75 | -15.45 |
| Financing Cash Flow Items | -382.56 | -87.58 | -23.43 | -3.32 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -79.97 | -1,854.52 | -982.10 | -319.61 |
Eris Lifesciences Dividend Eris Lifesciences Bonus Eris Lifesciences News Eris Lifesciences AGM Eris Lifesciences Rights Eris Lifesciences Splits Eris Lifesciences Board Meetings Eris Lifesciences Key Metrics Eris Lifesciences Shareholdings Eris Lifesciences Profit Loss Eris Lifesciences Balance Sheet Eris Lifesciences Q1 Results Eris Lifesciences Q2 Results Eris Lifesciences Q3 Results Eris Lifesciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks